Eckert & Ziegler Radiopharma GmbH has been granted marketing authorization (PL 46734/0001) for GalliaPharm^® from the Medicines & Healthcare products Regulatory Agency (MHRA) in the United Kingdom. This important milestone makes GalliaPharm^® available as a medicinal product in 13 European countries.

GalliaPharm^{® 68}Ge/⁶⁸Ga generator is a pharmaceutical product for the cyclotron-independent production of the positron emitter (⁶⁸Ga) Gallium, giving a lot of flexibility when it comes to patient scheduling.  ⁶⁸Ga-labeled medicinal products are used in Positron Emission Tomography (PET) in the diagnosis of cancer.

The successful approval process makes GalliaPharm^® the first ⁶⁸Ge/⁶⁸Ga generator registered as a medicinal product in the UK; thus, makes ⁶⁸Ga available for use with SOMAKIT TOC^® and clinical trials with [⁶⁸Ga]Ga-PSMA-HBED-CC for PET diagnostics.

For more information about GalliaPharm® and its registration please contact our UK distributor Imaging Equipment Limited or fill the contact form below.